For years the cancer remained crushed inside flat images, slides, thin sections observed under the microscope. They were enough to see a lot, but they left out one crucial thing: the shape. Now that form has emerged with a clarity that changes the way we look at breast cancer metastasis.
A research group bringing together the University of Padua, the Veneto Oncology Institute and IFOM has published on Cell a study that reconstructs metastatic growth in three dimensions and shows a different scene from the one we have been telling ourselves for years. Inside the tissue you can’t see a confusing mass that spreads haphazardly. We see an ordered structure, a network of cellular cords that stretch, divide, branch and occupy space following a precise logic.
The discovery is significant because it shifts attention from proliferation alone to construction. In the paper the authors explain that they combined single-cell RNA sequencing, spatial transcriptomics, 3D imaging supported by artificial intelligence and functional tests in mouse models to understand how the expansion of macrometastases occurs. From this work emerges a three-dimensional morphogenetic program essential to their growth: instead of the classic compact mass, the metastasis takes shape as a branched, open framework, efficient in invading the tissue.
Metastatic cells, according to the study, reactivate a biological logic that recalls the processes of embryonic development, those that at the beginning of life serve to build tissues and organs. Carried into cancer, that same ability becomes a lethal advantage. Breast cancer metastases, seen in this way, resemble a biological construction site with rules, geometry and a precise economy of space. This is the point that makes the discovery so important: where there is a plan, there can also be a point of failure.
In the work this architecture is linked to a group of genes indicated as true “architect genes”: the ETV genes. Their task, essentially, concerns the spatial organization of tumor cells. They give instructions on how to branch, how to arrange themselves, how to assemble the three-dimensional structure that the metastasis needs to become large and visible. When these genes are silenced, the tumor can remain alive and can even disseminate, but in most cases it loses the ability to build obvious metastases with that branched pattern that makes them so aggressive.
That point of failure that is of more interest today than suggestion
Inside this story there is also a therapeutic path, to be handled with caution and without selling miracles. The institutional sources accompanying the paper indicate the FGF signal, the fibroblast growth factor, as one of the vulnerabilities of the process. We are talking about a molecule crucial for the formation of branched structures in living organisms. Blocking it, the researchers explain, hinders metastatic growth and leaves the primary tumor largely intact: the cells survive, but struggle to build the final disseminated structure that transforms the disease into its most dangerous phase.
This fact must be told with our feet on the ground. The study opens a very serious biological path, but remains within the field of experimental and preclinical research. No one can transform it today into a ready cure or an immediate breakthrough for those who are sick. The value, if anything, lies in having indicated a construction logic and a possible Achilles’ heel within that logic. It is a huge step for those who study metastasis, precisely because the metastatic phase remains the most difficult to treat and has a decisive impact on oncological mortality. The same project sources point out that approximately 90% of cancer deaths are linked to metastases.
There is another passage that deserves attention, perhaps even more than the charm of the 3D title. The researchers explain that some primary breast tumors appear to already carry this branching program within them, while others lack it. Tumors with a more branched architecture are associated with the ability to metastasize; the more compact and solid ones instead resemble tumors which remain more controllable. In practice, the branching program could function as an early clue to the tendency to spread.
Here we understand well why research matters even outside the laboratory of great words. If this key holds up in subsequent studies, the tumor can also be read as an architecture, as well as a set of mutations, growth speed and response to drugs. For oncology it means trying to distinguish more precisely which lesions really have the design to build distant metastases. For patients, in the future, it could translate into finer tools to estimate risk and choose more targeted strategies. Today it remains a prospect, already very concrete on a scientific level, still far from routine clinical use.
You might also be interested in:
